These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Effects of angiotensin-converting-enzyme inhibitors on progression to end-stage renal failure in chronic vascular rejection. Rustom R; Paraoan MT; Sells RA; Jackson MJ; Hammad A; Bakran A; Brown M; Ahmad RA; Williams PS; Bell GM; Sharma A; Bone JM Transplant Proc; 2001; 33(1-2):1175-6. PubMed ID: 11267244 [No Abstract] [Full Text] [Related]
58. Long-term follow-up study of renal transplant recipients. Hiraga S; Kitamura M; Kobayashi D; Hida M; Satoh T; Takeda M Transplant Proc; 1994 Aug; 26(4):2090-2. PubMed ID: 8066681 [No Abstract] [Full Text] [Related]
59. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment. Rostoker G; Ben Maadi A; Remy P; Lang P; Lagrue G; Weil B Nephrol Dial Transplant; 1995; 10(1):25-9. PubMed ID: 7724024 [TBL] [Abstract][Full Text] [Related]
60. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? Vogt L; Kocks MJ; Laverman GD; Navis G Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]